Here we can assess oestrogen metabolism to reduce cancer risk.
The Dutch test with its 35 biomarkers focuses on evaluating how effectively your body detoxifies oestrogen. This is important because certain oestrogen metabolites when elevated pose cancer risks.
With the Dutch test we can review oestrogen metabolites and ratios – so how you are safely metabolising these.
Here are some clinical studies highlighting the importance of assessing these metabolites and ratios:
- Higher 2OH levels (good oestrogen pathway) are linked to a 28% reduction in breast cancer (BC) risk (Ziegler R, et al. 2009)
- Higher 2OH (good oestrogen pathway) metabolites were associated with decreased breast cancer (BC) risk (Moore SC et al, 2016)
- Higher 16OH (ugly oestrogen pathway) metabolites were associated with increased risk of breast cancer (BC) risk (Moore SC et al, 2016)
- Higher 4OH (bad oestrogen pathway) were associated with an increased risk of breast cancer (Fuhrman, et al 2012, Miao S et al, 2019)
- By optimising both your 2:16 and 2:4 oestrogen ratios, you'll reduce your breast cancer risk and also lower all-cause mortality (Wang T, et al. 2020)
With these personalised insights we can assess and optimise your oestrogen clearance, reduce symptoms of any oestrogen dominance, and support overall breast health.
So start understanding your hormones today for a healthier you.
If you’d like to know more about the Dutch Hormone Test – drop the functional and conventional medicine team a message and get you free 15 min discovery call.
Comments